Showing 971-980 of 1236 results for "".
- Allergan Aesthetics Panel: Medical Weight Loss Fuels New Aesthetic Conversationshttps://modernaesthetics.com/news/allergan-aesthetics-panel-medical-weight-loss-fuels-new-aesthetic-conversations/2485952/Experts at Allergan Aesthetics’ “Navigating the New Era of Patient Needs” virtual event highlighted how GLP-1 receptor agonists (GLP-1 RAs) are changing facial aesthetic concerns, patient education, and treatment sequencing. Th
- Top Plastic Surgeon Leads Study on Stackable Medical Grade Skincarehttps://modernaesthetics.com/news/top-plastic-surgeon-leads-study-stackable-medical-grade-skincare/2473587/A new study in the Aesthetic Surgery Journal led by Few, MD, shows positive results for using a stackable skincare routine. The use of stackable skincare can help streamline patients to treat primary concerns without causing irritation that can sometimes come from patients layerin
- Here’s What’s Been Happening at Merz Aestheticshttps://modernaesthetics.com/news/heres-whats-been-happening-at-merz-aesthetics/2472979/Merz Aesthetics is launching its new “confidence to be” branding platform following the conclusion of the company’s reorganization. Merz is now three independently operating businesses: medical aesthetics, therapeutics and consumer care. “The new brand
- Neauvia Granted CE Marking Under the E.U.’s New MDR for Facial Dermal Filler Linehttps://modernaesthetics.com/news/neauvia-granted-ce-marking-under-the-eus-new-mdr-for-facial-dermal-filler-line/2473362/Neauvia scored CE marking under the European Union’s new MDR (Medical Device Regulation) for its range of facial dermal fillers products, making it the first medical aesthetics business to receive such certification in Europe. The new regulation aims to create ‘a robus
- ellacor Maker Cytrellis Closes Funding Roundhttps://modernaesthetics.com/news/ellacor-maker-cytrellis-closes-funding-round/2473145/Cytrellis has closed a $50 million Series C funding round. The financing was led by D1 Capital Partners and included participation from an additional new investor, Sands Capital, as well as existing institutional investors, ARCH Venture Partners and PFM Health Sciences. Proceeds will be
- Abbvie’s Allergan: 1, Evolus: O in First Round of Trade Disputehttps://modernaesthetics.com/news/abbvies-allergan-1-evolus-o-in-first-round-of-trade-dispute/2472962/Evolus' and Daewoong Pharma's Jeuveau lost the first round in a trade dispute with AbbVie's Allergan and its Korean partner Medytox that sought to block imports of the Botox rival, but the match is not over yet. AbbVie's Allergan and its Korean partner Medytox
- What is Exosome Therapy? All Your Questions Answeredhttps://modernaesthetics.com/news/what-is-exosome-therapy-all-your-questions-answered/2473445/Exosomes are among today’s buzziest skincare ingredients, but what exactly are exosomes, how can you choose the best product to recommend to patients, and how can exosomes be used to complement in-office skin rejuvenation procedures? New York City dermatologist Marina I. Pere
- Suneva's Silhouette InstaLift Recognized with New Beauty Awardhttps://modernaesthetics.com/news/sunevas-silhouette-instalift-recognized-with-new-beauty-award/2473219/Suneva Medical, Inc.'s non-surgical thread lift, Silhouette InstaLift®, is the Best Thread Lift Treatment in NewBeauty's 2022 Beauty Awards. It uses collagen-stimulating absorbable sutures that offer patients immediate and lasting results with minimal recovery time.
- Managing Employees During the COVID Pandemic: Answers to Top Questionshttps://modernaesthetics.com/news/managing-employees-in-the-covid-pandemic-answers-to-top-questions/2473040/Can I require staff to get a vaccine in order to continue working? In many cases, vaccines can be required, says Josh Alloy, JD, Counsel at Arnold and Porter in Washington, DC, “although there are potential e
- Report: Nonsurgical Aesthetics Revenues Up 9% From Last Yearhttps://modernaesthetics.com/news/report-nonsurgical-aesthetics-revenues-up-9-from-last-year/2473677/Data and analytics solutions provider Guidepoint Qsight and investment banking and management consulting firm Skytale Group released a new report on the state of the aesthetics industry, highlighting the continued expansion of the US market. Combined nonsurgical revenues increased by 9%